Specify a stock or a cryptocurrency in the search bar to get a summary
Eurobio Scientific SA
ALERSEurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients' immune status against tetanus; and EBX molecular biology family, which includes a range of tests for identifying various pathogens responsible for infectious diseases and assessing the magnitude of the infection. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France. Address: 7 avenue de Scandinavie, Les Ulis, France, 91940
Analytics
WallStreet Target Price
28.37 EURP/E ratio
41.5323Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ALERS
Dividend Analytics ALERS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALERS
Stock Valuation ALERS
Financials ALERS
Results | 2019 | Dynamics |